|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.95 USD | +0.49% |
|
+3.76% | +3.12% |
| Jan. 20 | Wells Fargo Adjusts Price Target on Exelon to $51 From $52, Maintains Overweight Rating | MT |
| Jan. 13 | BMO Capital Adjusts Exelon Price Target to $48 From $51, Maintains Outperform Rating | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.08 | 2.17 | 1.9 | 2.55 | 2.55 | |||||
Return on Total Capital | 3.54 | 3.69 | 3.21 | 3.72 | 3.71 | |||||
Return On Equity % | 5.63 | 5.25 | 6.9 | 9.22 | 9.34 | |||||
Return on Common Equity | 6.06 | 5.09 | 6.94 | 9.22 | 9.34 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.12 | 28.35 | 42.53 | 41.22 | 40.84 | |||||
SG&A Margin | -0.16 | -0.25 | -0.33 | 0.08 | 0.16 | |||||
EBITDA Margin % | 27.89 | 26.34 | 32.9 | 31.34 | 31.22 | |||||
EBITA Margin % | 14.6 | 14.17 | 18.46 | 18.56 | 18.58 | |||||
EBIT Margin % | 12.81 | 12.51 | 18.15 | 18.52 | 18.54 | |||||
Income From Continuing Operations Margin % | 5.91 | 5.03 | 10.77 | 10.71 | 10.68 | |||||
Net Income Margin % | 5.94 | 4.69 | 11.37 | 10.71 | 10.68 | |||||
Net Avail. For Common Margin % | 5.94 | 4.69 | 10.76 | 10.71 | 10.68 | |||||
Normalized Net Income Margin | 6.64 | 6.7 | 8.14 | 7.83 | 7.13 | |||||
Levered Free Cash Flow Margin | -1.24 | -1.81 | -12.77 | -15.82 | -8.8 | |||||
Unlevered Free Cash Flow Margin | 1.85 | 0.89 | -8.03 | -10.84 | -3.53 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.26 | 0.28 | 0.17 | 0.22 | 0.22 | |||||
Fixed Assets Turnover | 0.41 | 0.44 | 0.28 | 0.3 | 0.3 | |||||
Receivables Turnover (Average Receivables) | 8.45 | 10.29 | 9.34 | 9.53 | 9.07 | |||||
Inventory Turnover (Average Inventory) | 13.23 | 14.5 | 16.41 | 16.42 | 16.47 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.98 | 0.87 | 0.69 | 0.81 | 0.87 | |||||
Quick Ratio | 0.46 | 0.43 | 0.38 | 0.4 | 0.48 | |||||
Operating Cash Flow to Current Liabilities | 0.33 | 0.19 | 0.46 | 0.49 | 0.58 | |||||
Days Sales Outstanding (Average Receivables) | 43.33 | 35.46 | 39.09 | 38.29 | 40.37 | |||||
Days Outstanding Inventory (Average Inventory) | 27.66 | 25.16 | 22.24 | 22.24 | 22.22 | |||||
Average Days Payable Outstanding | 56.57 | 53.64 | 94.4 | 88.68 | 78.15 | |||||
Cash Conversion Cycle (Average Days) | 14.43 | 6.98 | -33.07 | -28.15 | -15.56 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 116.54 | 125.04 | 163.11 | 172.16 | 174.23 | |||||
Total Debt / Total Capital | 53.82 | 55.56 | 61.99 | 63.26 | 63.53 | |||||
LT Debt/Equity | 104.89 | 105.42 | 145.2 | 156.59 | 161.78 | |||||
Long-Term Debt / Total Capital | 48.44 | 46.85 | 55.19 | 57.54 | 59 | |||||
Total Liabilities / Total Assets | 73.04 | 73.84 | 74.05 | 74.64 | 75.02 | |||||
EBIT / Interest Expense | 2.59 | 2.89 | 2.39 | 2.33 | 2.2 | |||||
EBITDA / Interest Expense | 5.96 | 6.36 | 4.39 | 3.98 | 3.74 | |||||
(EBITDA - Capex) / Interest Expense | 1.04 | 1.28 | -0.55 | -0.31 | 0.08 | |||||
Total Debt / EBITDA | 4.17 | 4.35 | 6.35 | 6.45 | 6.47 | |||||
Net Debt / EBITDA | 4.1 | 4.24 | 6.29 | 6.38 | 6.41 | |||||
Total Debt / (EBITDA - Capex) | 23.86 | 21.64 | -50.7 | -83.5 | 296.87 | |||||
Net Debt / (EBITDA - Capex) | 23.47 | 21.05 | -50.19 | -82.64 | 294.52 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -4.06 | 10.01 | 6.36 | 13.89 | 5.99 | |||||
Gross Profit, 1 Yr. Growth % | -2.88 | 3.54 | 14.2 | 10.38 | 5.01 | |||||
EBITDA, 1 Yr. Growth % | -3.27 | 3.86 | -36.28 | 8.49 | 5.57 | |||||
EBITA, 1 Yr. Growth % | -4.96 | 6.74 | 1.32 | 14.51 | 6.13 | |||||
EBIT, 1 Yr. Growth % | -6.06 | 7.42 | 20.54 | 16.23 | 6.09 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -35.47 | -6.4 | 27.1 | 13.34 | 5.67 | |||||
Net Income, 1 Yr. Growth % | -33.14 | -13.09 | 27.2 | 7.28 | 5.67 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -33.22 | -13.43 | 36.53 | 12.37 | 4.82 | |||||
Normalized Net Income, 1 Yr. Growth % | -6.93 | 10.9 | 59.71 | 9.48 | -3.45 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.89 | 2.06 | 6.96 | 6.5 | 6.17 | |||||
Inventory, 1 Yr. Growth % | -2.6 | 8.54 | 29.95 | 6.09 | 6.49 | |||||
Accounts Receivable, 1 Yr. Growth % | -29.64 | 9.24 | 18.62 | 5.64 | 16.91 | |||||
Total Assets, 1 Yr. Growth % | 3.47 | 2.86 | -28.32 | 6.5 | 5.82 | |||||
Tangible Book Value, 1 Yr. Growth % | 1.41 | 6.98 | -34.75 | 5.58 | 6.1 | |||||
Cash From Operations, 1 Yr. Growth % | -36.4 | -28.88 | 61.69 | -3.43 | 18.41 | |||||
Capital Expenditures, 1 Yr. Growth % | 10.41 | -0.83 | -10.45 | 3.65 | -4.2 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -47.94 | 60.93 | -175.16 | 41.1 | -41.03 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 174.9 | -47.34 | -137.85 | 53.86 | -65.5 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.52 | 0 | -11.76 | 6.67 | 5.56 | |||||
Common Equity, 1 Yr. Growth % | 1.12 | 5.55 | -28.06 | 4.09 | 4.53 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -4.17 | 2.73 | 7 | 10.06 | 9.87 | |||||
Gross Profit, 2 Yr. CAGR % | -0.26 | 0.15 | 13.48 | 13.06 | 7.89 | |||||
EBITDA, 2 Yr. CAGR % | -0.11 | 0.09 | -12.35 | -16.43 | 7.31 | |||||
EBITA, 2 Yr. CAGR % | -1.55 | 0.46 | 11.68 | 9.28 | 10.78 | |||||
EBIT, 2 Yr. CAGR % | -2.11 | 0.17 | 24.57 | 20.46 | 11.59 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -3.05 | -22.28 | 36.71 | 20.02 | 9.44 | |||||
Net Income, 2 Yr. CAGR % | -1.05 | -23.77 | 5.14 | 16.82 | 6.47 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.46 | -23.97 | 35.67 | 23.86 | 8.53 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.1 | 1.25 | 50.77 | 36.65 | 3.52 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.84 | 2.47 | -7.49 | 6.73 | 6.34 | |||||
Inventory, 2 Yr. CAGR % | 1.09 | 2.82 | -33.78 | 17.42 | 6.29 | |||||
Accounts Receivable, 2 Yr. CAGR % | -16.25 | -10.39 | -18.95 | 11.94 | 11.13 | |||||
Total Assets, 2 Yr. CAGR % | 3.97 | 3.16 | -14.13 | -12.63 | 6.32 | |||||
Common Equity, 2 Yr. CAGR % | 2.96 | 3.31 | -12.86 | -13.46 | 4.31 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.76 | 4.16 | -16.38 | -17 | 5.84 | |||||
Cash From Operations, 2 Yr. CAGR % | -30 | -32.75 | 7.24 | 24.96 | 6.94 | |||||
Capital Expenditures, 2 Yr. CAGR % | 1.92 | 4.64 | -5.76 | -3.66 | -0.35 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 42.18 | -7.51 | 114.88 | 3.98 | -9.18 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -27.8 | 16.15 | 130.03 | -23.1 | -27.64 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.29 | 2.72 | -6.07 | -2.99 | 6.11 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.52 | 0.34 | -17.87 | 9.25 | 8.68 | |||||
Gross Profit, 3 Yr. CAGR % | -0.55 | 0.99 | -7.56 | 12.44 | 10.31 | |||||
EBITDA, 3 Yr. CAGR % | -0.65 | 1.2 | -13.07 | -5.89 | -9.66 | |||||
EBITA, 3 Yr. CAGR % | -2.91 | 1.14 | -11.63 | 12.62 | 8.22 | |||||
EBIT, 3 Yr. CAGR % | -3.51 | 0.97 | -8.58 | 21.73 | 15.47 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -20.36 | -4.18 | -12.14 | 28.43 | 15.04 | |||||
Net Income, 3 Yr. CAGR % | -19.61 | -5.24 | -9.59 | 5.85 | 12.98 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -20.36 | -5.62 | -11.59 | 27.41 | 17.16 | |||||
Normalized Net Income, 3 Yr. CAGR % | -4.5 | 13.68 | -13.19 | 35.51 | 21.71 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.53 | 3.9 | -4.15 | -3.04 | 6.54 | |||||
Inventory, 3 Yr. CAGR % | 1.41 | 3.51 | -24.7 | -22.52 | 13.66 | |||||
Accounts Receivable, 3 Yr. CAGR % | -11.82 | -7.16 | -21.55 | -11.47 | 13.57 | |||||
Total Assets, 3 Yr. CAGR % | 3.46 | 3.6 | -8.62 | -7.74 | -6.77 | |||||
Common Equity, 3 Yr. CAGR % | 2.91 | 3.81 | -8.43 | -7.54 | -7.84 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3.72 | 4.82 | -10.83 | -9.62 | -9.92 | |||||
Cash From Operations, 3 Yr. CAGR % | -17.27 | -29.63 | -9.9 | 3.56 | 22.74 | |||||
Capital Expenditures, 3 Yr. CAGR % | 2 | 0.99 | -0.65 | -2.72 | -3.84 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -34.5 | 48.18 | 46.72 | 86.77 | -13.93 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 8.16 | -35.01 | 85.76 | 101.17 | -41.13 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.31 | 3.5 | -2.35 | -2 | -0.22 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 2.33 | 2.99 | -10.68 | -9.6 | -7.73 | |||||
Gross Profit, 5 Yr. CAGR % | 4.36 | 2.44 | -4.32 | -2.19 | -1.75 | |||||
EBITDA, 5 Yr. CAGR % | 2.34 | 1.99 | -7.75 | -5.91 | -5.53 | |||||
EBITA, 5 Yr. CAGR % | -0.17 | 1.37 | -7.75 | -4.12 | -3.46 | |||||
EBIT, 5 Yr. CAGR % | -0.73 | 1.22 | -5.98 | -1.84 | -1.18 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -2.78 | 8.87 | -11.9 | 2.29 | -4.07 | |||||
Net Income, 5 Yr. CAGR % | -2.86 | 8.76 | -10.5 | 3.03 | -3.48 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.57 | 7.54 | -12.17 | 2.46 | -4.03 | |||||
Normalized Net Income, 5 Yr. CAGR % | 0.18 | 6.26 | -9.22 | 0.53 | -7.11 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 8.49 | 3.93 | -0.46 | 0.04 | -0.09 | |||||
Inventory, 5 Yr. CAGR % | 1.92 | 2.67 | -14.49 | -13.82 | -13.56 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.93 | -3.62 | -14 | -12.66 | -9.82 | |||||
Total Assets, 5 Yr. CAGR % | 6.28 | 2.97 | -3.97 | -3.23 | -2.92 | |||||
Common Equity, 5 Yr. CAGR % | 4.79 | 5.89 | -3.71 | -3.48 | -3.53 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.3 | 7.66 | -4.84 | -4.49 | -4.5 | |||||
Cash From Operations, 5 Yr. CAGR % | -11.07 | -18.66 | -8.22 | -11.46 | -3.51 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.09 | -1.37 | -1.18 | -0.89 | -0.53 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.83 | -20.9 | 10.8 | 76.13 | 21.32 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -8.5 | -22.74 | 25.92 | 14.95 | 27.75 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.29 | 3.96 | 0.6 | 0.85 | 0.95 |
- Stock Market
- Equities
- EXC Stock
- Financials Exelon Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















